Gapping down
In reaction to disappointing earnings/guidance:
- N/A.
Select EU financial related names showing weakness:
- BCS -2.4%, DB -2.1%, LYG -0.8%, BBVA -0.8%, CS -0.7%
Other news:
- XENT -14.8% (esults from study of the company's ASCEND investigational drug-coated sinus balloon -- trial did not meet its primary endpoint)
- JKS -5.1% (negatively impacted by removal of tariff exemption for bifacial solar panels)
- CSIQ -4.9% (negatively impacted by removal of tariff exemption for bifacial solar panels)
- HEXO -2.2% (announces resignation of CFO Michael Monahan, effective today; appoints Stephen Burwash as new CFO)
Analyst comments:
- MCRN -2.7% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- ALGN -1.5% (downgraded to Neutral from Buy at Guggenheim)
- WEN -1.3% (downgraded to Market Perform from Outperform at Cowen)
- MLHR -1.2% (downgraded to Mkt Perform from Outperform at Raymond James)
- HPQ -0.7% (downgraded to Hold from Buy at Argus)
- NFLX -0.6% (target lowered to $300 from $380 at Evercore ISI)